It has also been observed that epigenetic alterations in the SCN and hippocampus elicit cognitive decline and memory impairments in rodents [83], while a study in an APP/PS1 transgenic mouse model of AD has evidenced that circadian disturbances might occur early during the stage of AD pathogenesis [80]. The gene discussed is APP; the disease is Alzheimer disease.